Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Integra LifeSciences (NASDAQ: IART) has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare MedTech & Services Conference. CEO Mojdeh Poul and CFO Lea Knight will deliver a presentation on March 17, 2025, at 10:00am ET.
The global medical technology company will provide a live webcast of the presentation, which will be accessible through their investor relations website at investor.integralife.com/events-and-presentations.
Integra LifeSciences (NASDAQ: IART) ha annunciato la sua partecipazione alla prossima 35a Conferenza Annuale MedTech & Servizi Sanitario di Oppenheimer. Il CEO Mojdeh Poul e Il CFO Lea Knight presenteranno il loro intervento il 17 marzo 2025, alle 10:00 ET.
La compagnia globale di tecnologia medica fornirà una trasmissione in diretta della presentazione, che sarà accessibile attraverso il loro sito web per le relazioni con gli investitori all'indirizzo investor.integralife.com/events-and-presentations.
Integra LifeSciences (NASDAQ: IART) ha anunciado su participación en la próxima 35ª Conferencia Anual de MedTech y Servicios de Salud de Oppenheimer. El CEO Mojdeh Poul y la CFO Lea Knight harán una presentación el 17 de marzo de 2025, a las 10:00 a.m. ET.
La compañía global de tecnología médica proporcionará una transmisión en vivo de la presentación, que estará disponible a través de su sitio web de relaciones con inversores en investor.integralife.com/events-and-presentations.
Integra LifeSciences (NASDAQ: IART)는 다가오는 Oppenheimer 제35회 연례 헬스케어 MedTech 및 서비스 컨퍼런스에 참여한다고 발표했습니다. CEO Mojdeh Poul과 CFO Lea Knight가 2025년 3월 17일 오전 10:00 ET에 발표를 진행할 예정입니다.
글로벌 의료 기술 회사는 발표의 실시간 웹캐스트를 제공하며, 이는 투자자 관계 웹사이트인 investor.integralife.com/events-and-presentations를 통해 접근할 수 있습니다.
Integra LifeSciences (NASDAQ: IART) a annoncé sa participation à la prochaine 35ème Conférence Annuelle MedTech et Services de Santé d'Oppenheimer. Le PDG Mojdeh Poul et la CFO Lea Knight présenteront le 17 mars 2025 à 10h00 ET.
La société mondiale de technologie médicale proposera un webinaire en direct de la présentation, accessible via leur site web des relations investisseurs à l'adresse investor.integralife.com/events-and-presentations.
Integra LifeSciences (NASDAQ: IART) hat seine Teilnahme an der bevorstehenden 35. jährlichen MedTech- und Gesundheitsdienstleistungskonferenz von Oppenheimer angekündigt. CEO Mojdeh Poul und CFO Lea Knight werden am 17. März 2025 um 10:00 Uhr ET eine Präsentation halten.
Das globale Medizintechnikunternehmen wird einen Live-Webcast der Präsentation anbieten, der über ihre Investoren-Relations-Website unter investor.integralife.com/events-and-presentations zugänglich sein wird.
- None.
- None.
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at https://investor.integralife.com/events-and-presentations.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
When is Integra LifeSciences (IART) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch Integra LifeSciences (IART) Oppenheimer Conference presentation?
Who will represent IART at the 2025 Oppenheimer Healthcare Conference?
Which healthcare conference is IART participating in March 2025?
